tiprankstipranks
Trending News
More News >
BioView Ltd. (IL:BIOV)
:BIOV
Israel Market

Bio View (BIOV) Ratios

Compare
0 Followers

Bio View Ratios

IL:BIOV's free cash flow for Q2 2024 was 0.67. For the 2024 fiscal year, IL:BIOV's free cash flow was decreased by and operating cash flow was 0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.11 2.68 3.11 3.43 3.24
Quick Ratio
2.59 2.15 2.59 2.88 2.68
Cash Ratio
1.97 1.32 1.97 2.30 2.20
Solvency Ratio
0.15 0.15 0.15 0.28 0.24
Operating Cash Flow Ratio
0.10 0.01 0.10 0.39 0.10
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
15.43M 17.28M 17.10M 15.87M 16.59M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.08 0.10 0.12 0.04
Debt-to-Equity Ratio
0.14 0.13 0.14 0.17 0.06
Debt-to-Capital Ratio
0.13 0.11 0.13 0.15 0.06
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.48 1.54 1.48 1.47 1.35
Debt Service Coverage Ratio
9.82 8.08 9.82 15.23 47.22
Interest Coverage Ratio
4.88 2.46 4.88 12.72 26.11
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.31 0.03 0.31 0.35 0.11
Net Debt to EBITDA
-3.29 -4.16 -5.90 -3.62 -6.50
Profitability Margins
Gross Profit Margin
57.20%61.48%57.20%57.63%60.80%
EBIT Margin
3.81%3.19%3.81%9.55%4.57%
EBITDA Margin
8.94%8.42%8.94%13.22%9.36%
Operating Profit Margin
3.95%2.20%3.95%9.67%4.63%
Pretax Profit Margin
3.00%2.29%3.00%8.79%4.40%
Net Profit Margin
2.01%1.10%2.01%7.16%3.41%
Continuous Operations Profit Margin
2.01%1.10%2.01%7.16%3.41%
Net Income Per EBT
67.09%48.06%67.09%81.40%77.48%
EBT Per EBIT
76.02%104.05%76.02%90.95%95.00%
Return on Assets (ROA)
6.83%0.91%1.40%5.46%2.61%
Return on Equity (ROE)
10.12%1.40%2.08%8.04%3.53%
Return on Capital Employed (ROCE)
12.53%2.55%3.59%9.32%4.61%
Return on Invested Capital (ROIC)
9.04%1.16%2.32%7.34%3.43%
Return on Tangible Assets
6.83%0.91%1.40%5.46%2.61%
Earnings Yield
0.06%0.83%0.01%0.05%0.02%
Efficiency Ratios
Receivables Turnover
5.51 4.69 5.51 6.91 8.05
Payables Turnover
7.50 5.22 7.50 10.10 8.65
Inventory Turnover
2.40 2.12 2.40 2.81 2.32
Fixed Asset Turnover
5.69 8.43 5.69 5.70 11.84
Asset Turnover
0.70 0.83 0.70 0.76 0.77
Working Capital Turnover Ratio
1.41 1.70 1.41 1.61 1.48
Cash Conversion Cycle
104.86 179.71 169.65 146.59 160.10
Days of Sales Outstanding
43.86 77.77 66.19 52.85 45.32
Days of Inventory Outstanding
92.24 171.88 152.14 129.88 157.00
Days of Payables Outstanding
31.25 69.94 48.69 36.14 42.22
Operating Cycle
136.11 249.66 218.33 182.73 202.31
Cash Flow Ratios
Operating Cash Flow Per Share
0.07 <0.01 0.07 0.23 0.06
Free Cash Flow Per Share
0.04 >-0.01 0.04 0.19 0.04
CapEx Per Share
0.03 <0.01 0.03 0.05 0.02
Free Cash Flow to Operating Cash Flow
0.53 -0.79 0.53 0.80 0.62
Dividend Paid and CapEx Coverage Ratio
2.12 0.56 2.12 4.93 2.64
Capital Expenditure Coverage Ratio
2.12 0.56 2.12 4.93 2.64
Operating Cash Flow Coverage Ratio
0.24 0.04 0.24 0.70 0.55
Operating Cash Flow to Sales Ratio
0.03 <0.01 0.03 0.11 0.03
Free Cash Flow Yield
0.05%-0.26%<0.01%0.06%<0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
8.72K 119.87 8.72K 2.09K 6.38K
Price-to-Sales (P/S) Ratio
175.70 1.32 175.70 149.73 217.20
Price-to-Book (P/B) Ratio
181.10 1.68 181.10 168.22 224.91
Price-to-Free Cash Flow (P/FCF) Ratio
10.02K -379.43 10.02K 1.77K 11.32K
Price-to-Operating Cash Flow Ratio
5.29K 300.07 5.29K 1.41K 7.03K
Price-to-Earnings Growth (PEG) Ratio
-126.89 -1.27 -126.89 12.55 -95.67
Price-to-Fair Value
181.10 1.68 181.10 168.22 224.91
Enterprise Value Multiple
1.96K 11.53 1.96K 1.13K 2.31K
Enterprise Value
4.30B 33.73M 5.11B 4.55B 5.62B
EV to EBITDA
869.18 11.53 1.96K 1.13K 2.31K
EV to Sales
120.02 0.97 175.18 149.25 216.59
EV to Free Cash Flow
1.88K -278.74 9.99K 1.76K 11.29K
EV to Operating Cash Flow
1.72K 220.44 5.27K 1.40K 7.01K
Tangible Book Value Per Share
2.03 0.20 2.03 1.94 1.78
Shareholders’ Equity Per Share
2.03 0.20 2.03 1.94 1.78
Tax and Other Ratios
Effective Tax Rate
0.33 0.52 0.33 0.19 0.23
Revenue Per Share
2.10 0.26 2.10 2.18 1.85
Net Income Per Share
0.04 <0.01 0.04 0.16 0.06
Tax Burden
0.75 0.48 0.67 0.81 0.77
Interest Burden
0.98 0.72 0.79 0.92 0.96
Research & Development to Revenue
0.16 0.24 0.17 0.17 0.21
SG&A to Revenue
0.06 0.22 0.11 0.06 0.07
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
0.74 0.19 1.11 1.21 0.70
Currency in ILS
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis